| Adverse effects: 4b. Other ‐ average endpoint weight loss (average weight in kg) (skewed) | ||||
|---|---|---|---|---|
| Study | Intervention | Mean(kg) | SD | N |
| short term (up to 12 weeks) | ||||
| Conley 2005 | Fluphenazine | ‐2.6 | 5.7 | 13 |
| Conley 2005 | Risperidone | ‐0.65 | 2.43 | 13 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.